DalsnaFinance › Analyst accuracy › UBS › ABBV target
ABBV Maintained by UBS -- Price Target Raised to $260
On %B %d, %Y, UBS analyst Michael Yee maintained a 'Neutral' rating for AbbVie (ABBV), while increasing the price target from $230.00 to $260.00, reflecting a 13.04% change in expected stock value.
A fact about what UBS published, as reported by GuruFocus, not a recommendation from Dalsna Finance; UBS is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.